Low ER+ Breast Cancer: Is This a Distinct Group?

Conclusions The low ER+/HER2- cases have morphologic features and a response to the chemotherapy rate that are more similar to triple-negative tumors than the usual type of ER+ tumors. PMID: 24713741 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24713741?dopt=Abstract

Source: Clinical Breast Cancer - April 11, 2014 Category: Cancer & Oncology Authors: Gloyeske NC, Dabbs DJ, Bhargava R Tags: Am J Clin Pathol Source Type: research